353
Participants
Start Date
August 29, 2022
Primary Completion Date
October 31, 2026
Study Completion Date
April 30, 2027
ACR-368
ACR-368 is an experimental drug
Gemcitabine
Sensitization of tumor cells is provided through administration of ULDG
OncoSignature
Prospective prediction of drug sensitivity based on a pretreatment tumor biopsy
RECRUITING
Laura & Isaac Perlmutter Cancer Center, New York
RECRUITING
New York Presbyterian Hospital-Columbia University Medical Center, New York
RECRUITING
Memorial Sloan-Kettering Cancer Center, New York
RECRUITING
Mount Sinai Health System, New York
RECRUITING
University of Rochester Medical Center, Rochester
RECRUITING
West Penn Hospital, Pittsburgh
ACTIVE_NOT_RECRUITING
Fox Chase Cancer Center, Philadelphia
COMPLETED
American Oncology Partners of Maryland PA, Bethesda
RECRUITING
National Institutes of Health, Clinical Center, Bethesda
COMPLETED
Holy Cross Hospital, Silver Spring
RECRUITING
University of Virginia Health System, Charlottesville
RECRUITING
Virginia Commonwealth University, Richmond
COMPLETED
University of North Carolina at Chapel Hill, Chapel Hill
RECRUITING
FirstHealth of the Carolinas, Pinehurst
RECRUITING
Emory University, Atlanta
COMPLETED
Northeast Georgia Medical Center, Gainesville
RECRUITING
Mount Sinai Comprehensive Cancer Center, Miami Beach
RECRUITING
Florida Gynecologic Oncology/Regional Cancer Center, Fort Myers
COMPLETED
University of South Alabama Mitchell Cancer Institute, Mobile
RECRUITING
Ohio State University, Hilliard
COMPLETED
Cleveland Clinic Foundation, Cleveland
COMPLETED
Gabrail Cancer Center, Canton
RECRUITING
University of Cincinnati Cancer Center, Cincinnati
RECRUITING
Miami Valley Hospital South, Centerville
RECRUITING
Ascension St. Vicent Hospital, Inc., Indianapolis
RECRUITING
Karmanos Cancer Institute, Detroit
RECRUITING
University of Iowa, Iowa City
RECRUITING
Froedtert and Medical College of Wisconsin, Milwaukee
RECRUITING
Sanford Health, Sioux Falls
RECRUITING
Northwestern Medicine, Chicago
RECRUITING
University of Illinois Cancer Center, Chicago
RECRUITING
University of Chicago Medicine, Chicago
RECRUITING
Carle Cancer Center, Urbana
RECRUITING
HCA Midwest, Kansas City
RECRUITING
LSU Health Sciences, New Orleans
RECRUITING
Trials365, LLC, Shreveport
RECRUITING
University of Arkansas for Medical Sciences, Little Rock
RECRUITING
Stephenson Cancer Center at OU Health, Oklahoma City
COMPLETED
Texas Oncology-Dallas Presbyterian Hospital, Dallas
RECRUITING
University of Texas Southwestern Medical Center, Dallas
COMPLETED
Texas Oncology, Fort Worth
RECRUITING
University of Texas, MD Anderson Cancer Center, Houston
RECRUITING
University of Colorado, Aurora
RECRUITING
Huntsman Cancer Institute, University of Utah, Salt Lake City
RECRUITING
HonorHealth, Phoenix
RECRUITING
Arizona Oncology Associate, PC- HOPE, Tucson
COMPLETED
USC/Norris Comprehensive Cancer Center, Los Angeles
RECRUITING
Cedars Sinai Medical Center, Los Angeles
RECRUITING
University of California Los Angeles (UCLA), Santa Monica
RECRUITING
City of Hope National Medical Center, Duarte
RECRUITING
UC San Diego Moores Cancer Center, La Jolla
RECRUITING
Hoag Cancer Center, Newport Beach
ACTIVE_NOT_RECRUITING
UC Irvine Health, Orange
RECRUITING
Stanford Cancer Center, Palo Alto
RECRUITING
University of California, Davis Comprehensive Cancer Center, Sacramento
ACTIVE_NOT_RECRUITING
Oregon Health & Sciences University, Portland
ACTIVE_NOT_RECRUITING
Oncology Associates of Oregon, Eugene
RECRUITING
Swedish Cancer Center, Seattle
COMPLETED
Fred Hutchinson Cancer Center, Seattle
COMPLETED
Northwest Cancer Specialists, P.C., Vancouver
RECRUITING
Providence Sacred Heart Medical Center and Children's Hospital, Spokane
COMPLETED
Summit Cancer Center, Spokane
COMPLETED
Alaska Women's Cancer Center, Anchorage
COMPLETED
Yale Cancer Center, New Haven
RECRUITING
Dana Farber Cancer Institute, Boston
RECRUITING
University of Massachusetts Chan Medical School, Worcester
RECRUITING
John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
RECRUITING
Rutgers Cancer Institute of NJ, New Brunswick
RECRUITING
Women & Infants Hospital, Providence
Lead Sponsor
GOG Foundation
NETWORK
Acrivon Therapeutics
INDUSTRY